PfizerPFE
NYSE · USA · Segment 2 of 8 in the Medicine, pharma & life science value chain: Big pharma
Large American pharmaceutical group with a broad portfolio in vaccines, oncology and internal medicine.
Big pharma: Large, diversified pharmaceutical groups with broad portfolios across therapeutic areas.
Key metrics
Market cap
$138B
Price
$24.28
Today
+0.1%
Return YTD
−2.6%
Return 1Y
−5.1%
P/E
18.4
P/S
2.2
P/B
1.5
Data as of 2026-07-10 · updates daily after U.S. close
Theme exposure
In the value chain
Products & services
- Vaccines
- Oncology
- Internal medicine
Competitors
Risks
- Patent cliff
- Declining covid revenue
- Acquisition integration
Same segment: Big pharma
See where Pfizer sits in the full Medicine, pharma & life science map — every segment from upstream suppliers to end markets, with daily metrics.Open the Life science value chain →